Stock Taper 
OPALEYE MANAGEMENT INC.
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 CG Oncology Inc. | CGON | 17.79K | $1.26M |
 Inhibrx Biosciences Inc. | INBX | 20.29K | $1.92M |
 Hemab Therapeutics Holdings, Inc. Common Stock | COAG | 47.65K | $1.75M |
 First Tracks Biotherapeutics Inc | TRAX | 65K | $1.31M |
 Biohaven Ltd. | BHVN | 77.92K | $1.16M |
 Protagonist Therapeutics, Inc. | PTGX | 100K | $12.26M |
 Revolution Medicines, Inc. | RVMD | 100K | $18.73M |
 Rhythm Pharmaceuticals, Inc. | RYTM | 122.5K | $13.6M |
 Enanta Pharmaceuticals, Inc. | ENTA | 125K | $1.82M |
 Jade Biosciences, Inc. | JBIO | 145K | $3.22M |
 Phathom Pharmaceuticals, Inc. | PHAT | 185.59K | $2.01M |
 Atea Pharmaceuticals, Inc. | AVIR | 235K | $1.09M |
 Intellia Therapeutics, Inc. | NTLA | 250K | $4.23M |
 Trevi Therapeutics, Inc. | TRVI | 310K | $5.78M |
 4D Molecular Therapeutics, Inc. | FDMT | 334.44K | $4.45M |
 Journey Medical Corporation | DERM | 350K | $2.48M |
 Apogee Therapeutics, Inc. | APGE | 390K | $51.76M |
 Edgewise Therapeutics, Inc. | EWTX | 500K | $20.32M |
 TG Therapeutics, Inc. | TGTX | 535K | $29.39M |
 Alumis Inc. | ALMS | 550K | $15.48M |